Program for the Identification of "Actionable" Atrial Fibrillation in the Family Practice Setting — PIAAF-FP  

Atrial Fibrillation Clinical Trial

Official title: Program for the Identification of "Actionable" Atrial Fibrillation in the Family Practice Setting

Status Completed

Clinical Trial Summary

Atrial fibrillation (AF) is a major risk factor for stroke. The identification and treatment of AF is one of the best way to prevent stroke. The problem is that because AF may cause minimal symptoms, it often goes undetected before a patient suffers a stroke. Also, it is known that as many as half of all patients with known AF may not be receiving appropriate anticoagulation for their condition. New technologies are making it possible to improve AF detection. Subjects in this study will be screened for AF using three simple methods: a 30-second pulse check, a hand-held single-lead electrocardiogram (ECG) device and a blood pressure monitor with built-in AF screening capabilities. If more patients with AF can be detected, more patients will be able to receive guideline-recommended anticoagulant therapy, and more strokes, deaths, disability, and dementia will be prevented.

Clinical Trial Description

Participants will be screened for AF using three simple methods (pulse check, single-lead ECG, blood pressure machine with automated AF detection algorithms). Subjects screening positive on any test will attend for a 12-lead ECG within 24 h. For all patients with AF detected, clinical characteristics and medications will be compared at baseline and 90±14 days later. ;

Related Conditions & MeSH terms

• Atrial Fibrillation

• NCT number: NCT02262351
• Study type: Interventional
• Source: Population Health Research Institute
• Status: Completed
• Phase: N/A
• Start date: April 2015
• Completion date: December 2, 2016